Sudan Loganathan

Stock Analyst at Stephens & Co.

(0.99)
# 2,928
Out of 4,461 analysts
9
Total ratings
25%
Success rate
-15.02%
Average return
Main Sectors:

8 Stocks

Sensei Biotherapeutics
May 24, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.66
Upside: +658.73%
Exelixis
May 14, 2024
Initiates: Equal-Weight
Price Target: $23
Current: $22.20
Upside: +3.60%
Elevation Oncology
May 14, 2024
Initiates: Overweight
Price Target: $8
Current: $2.56
Upside: +212.50%
Nurix Therapeutics
May 14, 2024
Initiates: Overweight
Price Target: $20
Current: $21.30
Upside: -6.10%
Inovio Pharmaceuticals
May 14, 2024
Initiates: Overweight
Price Target: $20
Current: $8.09
Upside: +147.22%
Blueprint Medicines
May 14, 2024
Initiates: Overweight
Price Target: $140
Current: $104.23
Upside: +34.32%
Actinium Pharmaceuticals
May 14, 2024
Initiates: Overweight
Price Target: $25
Current: $7.31
Upside: +242.00%
Delcath Systems
May 14, 2024
Initiates: Overweight
Price Target: $25
Current: $8.06
Upside: +210.17%